Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay Boosting

11 Jan 2023

Abstract excerpt

Plasmonic metasurfaces (PMs) functionalized with the monoclonal antibody (mAb) are promising biophotonic sensors for biomolecular interaction analysis and convenient immunoassay of various biomarkers, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Previous PM biosensing suffers from the slow affinity detection rate and lack of sufficient immunoassay studies on various SARS-CoV-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biosensors and Analytical Detection
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36630157
DOI: 10.1021/acsnano.2c08153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay BoostingPMID 36630157Read ↗

Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical ValidationSemantic proximity Read ↗

Nano assembly of plasmonic probe-virus particles enabled rapid and ultrasensitive point-of-care SARS-CoV-2 detectionSemantic proximity Read ↗

Nanoparticle-Supported, Rapid, Digital Quantification of Neutralizing Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read ↗

Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves.Semantic proximity Read ↗

Nanoparticle-Supported, Rapid, and Electronic Detection of SARS-CoV-2 Antibodies and Antigens at Sub-Femtomolar LevelSemantic proximity Read ↗

Unraveling the Dynamics of SARS-CoV-2 Mutations: Insights from Surface Plasmon Resonance Biosensor KineticsSemantic proximity Read ↗

SARS-CoV-2 Virus-like Particles with Plasmonic Au Cores and S1-Spike Protein CoronasSemantic proximity Read ↗

Sensing of COVID-19 Antibodies in Seconds via Aerosol Jet Printed Three Dimensional ElectrodesSemantic proximity Read ↗

Ultra-sensitive label-free SERS biosensor with high-throughput screened DNA aptamer for universal detection of SARS-CoV-2 variants from clinical samplesSemantic proximity Read ↗

Rapid differentiation of SARS-CoV-2 variants on a nanotechnology enhanced DNA-chipSemantic proximity Read ↗

Development of Nucleocapsid-Specific Monoclonal Antibodies for SARS-CoV-2 and Their ELISA Diagnostics on an Automatic Microfluidic DeviceSemantic proximity Read ↗

An Aptamer-Based Point-of-Care Diagnostic Test Strip for Rapid Diagnosis of Surface Spike Proteins of Sars-Cov2 VirusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.